NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors

Summary

RATIONALE: NG-nitro-L-arginine may stop the growth of tumor cells by disrupting blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of NG-nitro-L-arginine in treating patients with advanced solid tumors.

Timeline

Start

2011-04

Primary completion

2012-09

Completion

2012-09

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications